Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Umut Emre Aykut, Umit Akyuz, Atakan Yesil, Fatih Eren, Fatma Gerin, Rabia Ergelen, Cigdem Ataizi Celikel & Yusuf Yilmaz. (2014) A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 49:11, pages 1343-1348.
Read now
Read now
Anna Alisi, Sara Ceccarelli & Valerio Nobili. (2012) Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy. Expert Opinion on Medical Diagnostics 6:5, pages 377-380.
Read now
Read now
Articles from other publishers (28)
Fulin Lu, Liang Du, Wei Chen, Hai Jiang, Chenwu Yang, Yu Pu, Jun Wu, Jiang Zhu, Tianwu Chen, Xiaoming Zhang & Changqiang Wu. (2022)
T
1
–
T
2
dual-modal magnetic resonance contrast-enhanced imaging for rat liver fibrosis stage
. RSC Advances 12:55, pages 35809-35819.
Crossref
Crossref
Mingli Jin, Yin Jiang, Qi Zhao, Zhihua Pan & Fang Xiao. (2022) Diagnostic value of T2 relaxation time for hepatic iron grading in rat model of fatty and fibrotic liver. PLOS ONE 17:12, pages e0278574.
Crossref
Crossref
Anca Trifan, Remus Stafie, Adrian Rotaru, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Camelia Cojocariu, Oana Petrea & Carol Stanciu. (2022) Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter. Journal of Clinical Medicine 11:19, pages 5959.
Crossref
Crossref
Hang Lyu, Haotong Tang, Yizhi Liang, Shaoli Huang, Yuyu Wang, Wenyan Huang & Yi Zhou. (2022) Alcohol Consumption and Risk of Liver Fibrosis in People Living With HIV: A Systematic Review and Meta-Analysis. Frontiers in Immunology 13.
Crossref
Crossref
Giovanni Targher, Alessandro Mantovani, Christoph Grander, Luisa Foco, Benedetta Motta, Christopher D. Byrne, Peter P. Pramstaller & Herbert Tilg. (2021) Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes—The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study. Nutrition, Metabolism and Cardiovascular Diseases 31:12, pages 3464-3473.
Crossref
Crossref
Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran & Yusuf Yilmaz. (2020) Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gut and Liver 14:4, pages 486-491.
Crossref
Crossref
Rebecca Mercedes, Jameisha Brown, Charles Minard, Cynthia M. Tsai, Sridevi Devaraj, Marthe Munden & Daniel Leung. (2020) A Liver Biopsy Validation Pilot Study of Shear Wave Elastography, APRI, FIB-4, and Novel Serum Biomarkers for Liver Fibrosis Staging in Children With Chronic Viral Hepatitis. Global Pediatric Health 7, pages 2333794X2093893.
Crossref
Crossref
Benedetta M. Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vukovic, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard, Deborah Mascalzoni, Alessandra Rossini, Cristian Pattaro, Herbert Tilg & Peter P. Pramstaller. (2019) Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. Journal of Translational Medicine 17:1.
Crossref
Crossref
Ju‐Seop Kang & Min‐Ho Lee. 2017. Liver Cirrhosis - Update and Current Challenges. Liver Cirrhosis - Update and Current Challenges.
Marcelo Soto, Laura Sampietro-Colom, Luis Lasalvia, Aurea Mira, Wladimiro Jiménez & Miquel Navasa. (2017) Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients. World Journal of Gastroenterology 23:17, pages 3163.
Crossref
Crossref
Rabia Ergelen, Yusuf Yilmaz, Ruslan Asedov, Cigdem Celikel, Hakan Akin, Onur Bugdayci, Ersan Altun & Davut Tuney. (2016) Comparison of Doppler ultrasound and transient elastography in the diagnosis of significant fibrosis in patients with nonalcoholic steatohepatitis. Abdominal Radiology 41:8, pages 1505-1510.
Crossref
Crossref
Olga H. Orasan, Mihaela Iancu, Madalina Sava, Aniela Saplontai-Pop, Angela Cozma, Simina Tarmure Sarlea, Corneliu Lungoci, Marius-Ionut Ungureanu, Vasile Negrean, Dorel Sampelean & Dan Lucian Dumitrascu. (2015) Non-invasive assessment of liver fibrosis in chronic viral hepatitis. European Journal of Clinical Investigation 45:12, pages 1243-1251.
Crossref
Crossref
Elif Dincses & Yusuf Yilmaz. (2015) Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 27:10, pages 1149-1153.
Crossref
Crossref
Rabia Ergelen, Umit Akyuz, Yucel Aydin, Fatih Eren & Yusuf Yilmaz. (2015) Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 27:6, pages 667-671.
Crossref
Crossref
Cemal F. Subasi, Umut E. Aykut & Yusuf Yilmaz. (2015) Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 27:2, pages 137-141.
Crossref
Crossref
Da-Wu Zeng, Jie-Min Zhang, Yu-Rui Liu, Jing Dong, Yin-Lian Wu, Su Lin, Jia-Ji Jiang & Yue-Yong Zhu. (2014) A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity. Clinics and Research in Hepatology and Gastroenterology 38:6, pages 727-734.
Crossref
Crossref
Seung Kim, Yunkoo Kang, Mi Jung Lee, Myung Joon Kim, Seok Joo Han & Hong Koh. (2014) Points to Be Considered When Applying FibroScan S Probe in Children With Biliary Atresia. Journal of Pediatric Gastroenterology & Nutrition 59:5, pages 624-628.
Crossref
Crossref
Hind I. Fallatah. (2014) Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014, pages 1-15.
Crossref
Crossref
CAIHUA ZHANG, YANFU WANG, HONG CHEN, GUANG YANG, SHAOPENG WANG, MIAONA JIANG, LI CONG, LIJUN YUAN, HANSHU LI & YUJIE JIA. (2013) Protective effect of the herbal medicine Gan-fu-kang against carbon tetrachloride-induced liver fibrosis in rats. Molecular Medicine Reports 8:3, pages 954-962.
Crossref
Crossref
Laurent Castera. (2011) Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatology International 5:2, pages 625-634.
Crossref
Crossref
Laurent Castera. (2011) Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Practice & Research Clinical Gastroenterology 25:2, pages 291-303.
Crossref
Crossref
M. Andrioli, M. Scacchi, C. Carzaniga, G. Vitale, M. Moro, L. Poggi, L.M. Fatti & F. Cavagnini. (2010) Thyroid nodules in acromegaly: The role of elastography. Journal of Ultrasound 13:3, pages 90-97.
Crossref
Crossref
Jérôme Guéchot, Elisabeth Lasnier, Nathalie Sturm, Adeline Paris & Jean-Pierre Zarski. (2010) Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort. Clinica Chimica Acta 411:1-2, pages 86-91.
Crossref
Crossref
Laurent Castéra, Juliette Foucher, Pierre-Henri Bernard, Françoise Carvalho, Daniele Allaix, Wassil Merrouche, Patrice Couzigou & Victor de Lédinghen. (2010) Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology, pages NA-NA.
Crossref
Crossref
Laurent Castera. (2009) Liver stiffness and hepatocellular carcinoma: Liaisons dangereuses?. Hepatology 49:6, pages 1793-1794.
Crossref
Crossref
Laurent Castera. (2009) Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Journal of Viral Hepatitis 16:5, pages 300-314.
Crossref
Crossref
L. Castera. (2009) Quels outils pour le diagnostic non invasif de la stéatose et de la fibrose chez les patients atteints de stéatopathie métabolique ?. Gastroentérologie Clinique et Biologique 33:5, pages 405-412.
Crossref
Crossref
L. Castera. (2008) Non-invasive diagnosis of steatosis and fibrosis. Diabetes & Metabolism 34:6, pages 674-679.
Crossref
Crossref